Institutional Ownership
Mediwound Ltd
CUSIP M68830112SHS NEWMDWDQ1 2026
13D / 13G Filings
14
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
16.2%
Max % of class reported
Institutional Holders
73
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
14 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | T. Rowe Price Associates, Inc. | 13G/A | 4.3% | 554.5K | SEC |
| 2 | Feb 5, 2026 | Yelin Lapidot Holdings Management Ltd. | 13G/A | 11.0% | 763.1K | SEC |
| 3 | Nov 14, 2025 | T. Rowe Price Associates, Inc. | 13G | 5.5% | 614.5K | SEC |
| 4 | Oct 3, 2025 | Access Industries Holdings LLC | 13D/A | 11.6% | — | SEC |
| 5 | Nov 14, 2024 | Point72 Asset Management, L.P. | 13G/A | 0.1% | 11.7K | SEC |
| 6 | Oct 1, 2024 | Yelin Lapidot Holdings Management Ltd. | 13G | 7.0% | 750.7K | SEC |
| 7 | Jul 19, 2024 | Access Industries Holdings LLC | 13D/A | 13.8% | 1.48M | SEC |
| 8 | Jul 19, 2024 | Molnlycke Health Care Ab | 13D | 8.1% | 872.1K | SEC |
| 9 | Jan 8, 2024 | Deep Insight Limited Partnership | 13G/A | 10.4% | 959.7K | SEC |
| 10 | Jan 8, 2024 | Israel Biotech Fund II, L.P. | 13G/A | 10.4% | 959.7K | SEC |
4 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Mediwound Ltd.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Investor Ab | 872.1K | $14.05M |
| 2 | Yelin Lapidot Holdings Management Ltd. | 762.8K | $12.29M |
| 3 | Rosalind Advisors, Inc. | 749.1K | $12.07M |
| 4 | Blackrock, Inc. | 445.8K | $7.18M |
| 5 | Meitav Investment House Ltd | 371.9K | $5.98M |
| 6 | Sphera Funds Management Ltd. | 273.2K | $4.40M |
| 7 | Silverberg Bernstein Capital Management LLC | 200.0K | $3.22M |
| 8 | Point72 Asset Management, L.P. | 175.5K | $2.83M |
| 9 | Ubs Group AG | 159.8K | $2.57M |
| 10 | State Street Corp | 143.8K | $2.32M |